Assessing Treatment-Selection Markers using a Potential Outcomes Framework

Measuring the Performance of Markers for Guiding Treatment Decisions

(2013) Holly Janes et al.   ANNALS OF INTERNAL MEDICINE

Design and Inference for Cancer Biomarker Study with an Outcome and Auxiliary-Dependent Subsampling

(2009) Xiaofei Wang et al.   BIOMETRICS

American Society of Clinical Oncology Provisional Clinical Opinion: Testing forKRASGene Mutations in Patients With Metastatic Colorectal Carcinoma to Predict Response to Anti–Epidermal Growth Factor Receptor Monoclonal Antibody Therapy

(2009) Carmen J. Allegra et al.   JOURNAL OF CLINICAL ONCOLOGY

Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis

(2009) Bryan E. Shepherd et al.   JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

(2009) R. M. Simon et al.   JNCI-Journal of the National Cancer Institute

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

(2009) Kathy S Albain et al.   LANCET ONCOLOGY

The Use of Genomics in Clinical Trial Design

(2008) R. Simon   CLINICAL CANCER RESEARCH

Various randomized designs can be used to evaluate medical tests

(2008) Jeroen G. Lijmer et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

(2008) Susan P Buchbinder et al.   LANCET

K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer

(2008) Christos S. Karapetis et al.   NEW ENGLAND JOURNAL OF MEDICINE